Prognostic value of morphological, biochemical, molecular markers of fibrosis in patients with hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM) at the cellular level is characterized by hypertrophy, cardiomyocyte disorganization and myocardial fibrosis areas. The leading death cause in HCM remains sudden cardiac death (SCD). Despite the existing risk scores for SCD in HCM, there are still patients with unce...
Saved in:
| Main Authors: | G. A. Burnasheva, R. P. Myasnikov, O. V. Kulikova, M. M. Kudryavtseva, E. A. Mershina, O. M. Drapkina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2023-12-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/3839 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systemic inflammation is associated with myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy
by: Xinli Guo, et al.
Published: (2025-02-01) -
SUDDEN DEATH IN HYPERTROPHIC CARDIOMYOPATHY: SEARCH FOR NEW RISK FACTORS
by: N. S. Krylova, et al.
Published: (2017-02-01) -
Correlation between markers of fibrosis and myocardial remodeling in patients with various course of hypertrophic cardiomyopathy
by: F. M. Bogatyreva, et al.
Published: (2022-03-01) -
Interdisciplinary approach to surgical treatment for patients with hypertrophic obstructive cardiomyopathy
by: K. V. Rudenko, et al.
Published: (2021-07-01) -
Clinical characteristics and long‐term outcomes in patients with apical hypertrophic cardiomyopathy
by: Meng Guo, et al.
Published: (2025-08-01)